Literature DB >> 24473924

Increased risk of malignant melanoma in patients with systemic mastocytosis?

Hans Hägglund1, Birgitta Sander, Theo Gülen, Bernt Lindelöf, Gunnar Nilsson.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24473924     DOI： 10.2340/00015555-1788

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  5 in total

1.  [Aggressive malignant melanoma in a patient with urticaria pigmentosa].

Authors:  Cristel Ruini; Daniela Hartmann; Michael J Flaig; Tanja von Braunmühl; Carola Berking
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

2.  The expression of melanoma inhibitory activity on mast cells in child patients with cutaneous mastocytosis.

Authors:  Yuko Ehara; Yuichi Yoshida; Makoto Tahira; Osamu Yamamoto
Journal:  Yonago Acta Med       Date:  2014-10-15       Impact factor: 1.641

3.  Analysis of V600E BRAF and D816V KIT mutations in systemic mastocytosis.

Authors:  H Hägglund; B Sander; A Ahmadi; T Gülen; G Nilsson
Journal:  Med Oncol       Date:  2014-07-18       Impact factor: 3.064

4.  Risk of solid cancer in patients with mast cell activation syndrome: Results from Germany and USA.

Authors:  Gerhard J Molderings; Thomas Zienkiewicz; Jürgen Homann; Markus Menzen; Lawrence B Afrin
Journal:  F1000Res       Date:  2017-10-26

5.  Clinical Outcomes of Adults with Systemic Mastocytosis: A 15-Year Multidisciplinary Experience.

Authors:  Johanna Ungerstedt; Christopher Ljung; Monika Klimkowska; Theo Gülen
Journal:  Cancers (Basel)       Date:  2022-08-16       Impact factor: 6.575
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.